Abstract
Durvalumab is an immune checkpoint inhibitor (ICI) belonging to the anti-programmed death-ligand 1 (PD-L1) class, and it is used in the treatment of v......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
